News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,990 Results
Type
Article (41464)
Company Profile (292)
Press Release (655234)
Section
Business (209616)
Career Advice (2057)
Deals (36552)
Drug Delivery (89)
Drug Development (82535)
Employer Resources (170)
FDA (16367)
Job Trends (15324)
News (354225)
Policy (33780)
Tag
Academia (2572)
Africa (774)
Alliances (50920)
Alzheimer's disease (1150)
Approvals (16310)
Arizona (176)
Artificial intelligence (74)
Asia (39578)
Australia (6308)
Bankruptcy (360)
Best Places to Work (11351)
Biosimilars (64)
Biotechnology (185)
C2C Services and Suppliers (79727)
California (1587)
Canada (840)
Cancer (336)
Career advice (1719)
Cell therapy (102)
China (115)
Clinical research (64447)
Collaboration (110)
Colorado (65)
Connecticut (62)
COVID-19 (2546)
Cystic fibrosis (74)
Data (147)
Diabetes (68)
Diagnostics (6026)
Drug pricing (67)
Earnings (85291)
Employer resources (143)
Europe (84015)
Events (110222)
Executive appointments (104)
FDA (16545)
Florida (216)
Funding (98)
Gene therapy (85)
GLP-1 (529)
Government (4398)
Healthcare (18753)
Hotbed/Location (489745)
Idaho (56)
Illinois (237)
Indiana (139)
Infectious disease (2570)
Inflammatory bowel disease (90)
Interviews (316)
IPO (16440)
Job creations (4044)
Job search strategy (1481)
Kansas (93)
Layoffs (408)
Legal (8289)
Lung cancer (71)
Manufacturing (77)
Maryland (350)
Massachusetts (1342)
Medical device (13098)
Medtech (13101)
Mergers & acquisitions (19911)
Metabolic disorders (230)
Michigan (115)
Minnesota (202)
Neuroscience (1271)
New Jersey (494)
New York (495)
NextGen Class of 2024 (6601)
Non-profit (4499)
North Carolina (573)
Northern California (725)
Obesity (141)
Ohio (98)
Opinion (191)
Patents (60)
Pennsylvania (522)
People (57657)
Pharmaceutical (84)
Phase I (19880)
Phase II (28361)
Phase III (21331)
Pipeline (96)
Postmarket research (2634)
Preclinical (8476)
Press Release (68)
Rare diseases (119)
Real estate (6227)
Recruiting (65)
Regulatory (21974)
Research institute (2349)
Resumes & cover letters (354)
South America (1151)
Southern California (641)
Startups (3704)
Texas (189)
United States (7552)
Vaccines (467)
Washington State (238)
Weight loss (127)
Date
Today (191)
Last 7 days (481)
Last 30 days (2301)
Last 365 days (38210)
2024 (25067)
2023 (40630)
2022 (51798)
2021 (56332)
2020 (54795)
2019 (47402)
2018 (35772)
2017 (33139)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27633)
2012 (29731)
2011 (30488)
2010 (28497)
696,990 Results for "amylin pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Viking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes Association
Viking Therapeutics, Inc. today announced the presentation of preclinical data from a series of internally developed dual agonists of the amylin and calcitonin receptors at the 84th Scientific Sessions of the American Diabetes Association.
June 24, 2024
·
6 min read
Drug Development
Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide
Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide
June 20, 2024
·
9 min read
Drug Development
Sciwind Biosciences to Highlight Positive Results for Injectable Ecnoglutide (Phase 3), Oral Ecnoglutide (Phase 1), and Novel Amylin Analogs at the American Diabetes Association (ADA) 84th Annual Conference
Sciwind Biosciences Co., Ltd. announced that the company will present positive results from a Phase 3 clinical study of injectable ecnoglutide in T2DM patients and from a Phase 1 study for oral ecnoglutide in healthy and healthy obese participants, as well as preclinical data for novel amylin analog programs, at the American Diabetes Association 84th Annual Conference.
June 21, 2024
·
3 min read
Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek
Zealand Pharma A/S announced presentations of clinical and non-clinical results for Zealand’s amylin analog ZP8396 at the Obesity Society Annual Meeting being held in Dallas, Texas from October 14-17, 2023.
October 17, 2023
·
6 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
BioMidwest
Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy
Nika Pharmaceuticals, Inc. introduces its plans to develop the company into a sustainable business project that will consistently grow, bring good profits and provide dividends to its shareholders.
June 3, 2024
·
5 min read
BioMidwest
Bexion Pharmaceuticals, Inc. to Present at BIO International Convention 2024
Bexion Pharmaceuticals, Inc. announced that the Company will present at the 2024 Biotechnology Innovation Organization International Convention taking place June 3-6, 2024, in San Diego, California.
May 31, 2024
·
2 min read
Deals
Future Pak Issues Enhanced and Final Proposal to Acquire Vanda Pharmaceuticals Inc.
Future Pak, LLC and its affiliates announced that it has submitted a final attempt to engage with Vanda Pharmaceuticals Inc. in a good faith effort to acquire all outstanding shares of Vanda.
June 13, 2024
·
4 min read
Pharm Country
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical stage pharmaceutical company, today announced that management will participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on Thursday, June 27, 2024.
June 20, 2024
·
2 min read
Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396
Zealand Pharma A/S announced results from Part 1 of a multiple ascending dose trial for ZP8396, the company’s long-acting amylin analog with potential for the management of overweight and obesity.
July 3, 2023
·
6 min read
1 of 69,699
Next